Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
TNXP Tonix Pharmaceuticals Holding Corp
- Stocks
- Healthcare
- NASDAQ: TNXP
Price (delayed)
$37.69
Market cap
$276.07M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1,664.44
Enterprise value
$144.91M
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing small molecules and biologics to treat and prevent human disease and alleviate suffering. Tonix's
Highlights
TNXP's quick ratio has soared by 99% from the previous quarter
The debt has dropped by 94% year-on-year and by 93% since the previous quarter
TNXP's gross margin is up by 29% from the previous quarter but it is down by 21% YoY
The gross profit has grown by 29% from the previous quarter but it has contracted by 22% YoY
The net income has declined by 34% year-on-year
The company's revenue fell by 2% YoY
Key stats
What are the main financial stats of TNXP
Market
Valuations
Earnings
Shares outstanding
7.32M
Market cap
$276.07M
Enterprise value
$144.91M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.34
Price to sales (P/S)
22.25
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.43
Revenue
$10.04M
Gross profit
$2.99M
Operating income
-$131.4M
Net income
-$131.93M
EBIT
-$131.93M
EBITDA
-$129.22M
Free cash flow
-$59.95M
Per share
Balance sheet
Liquidity
EPS
-$1,664.44
EPS diluted
-$1,664.44
Free cash flow per share
-$10.11
Book value per share
$28.03
Revenue per share
$1.69
TBVPS
$32.52
Total assets
$192.87M
Total liabilities
$12.47M
Debt
$563,000
Equity
$180.4M
Working capital
$137.43M
Debt to equity
0
Current ratio
12.31
Quick ratio
11.12
Net debt/EBITDA
1.01
Margins
Efficiency
Dividend
EBITDA margin
-1,286.9%
Gross margin
29.8%
Net margin
-1,313.9%
Operating margin
-1,308.7%
Return on assets
-101.3%
Return on equity
-121%
Return on invested capital
-243.6%
Return on capital employed
-73%
Return on sales
-1,313.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TNXP stock price
How has the Tonix Pharmaceuticals Holding stock price performed over time
Intraday
1.89%
1 week
33.04%
1 month
121.32%
1 year
-93.07%
YTD
14.28%
QTD
110.85%
Financial performance
How have Tonix Pharmaceuticals Holding's revenue and profit performed over time
Revenue
$10.04M
Gross profit
$2.99M
Operating income
-$131.4M
Net income
-$131.93M
Gross margin
29.8%
Net margin
-1,313.9%
The net margin has declined by 37% year-on-year
The net income has declined by 34% year-on-year
TNXP's gross margin is up by 29% from the previous quarter but it is down by 21% YoY
The gross profit has grown by 29% from the previous quarter but it has contracted by 22% YoY
Price vs fundamentals
How does TNXP's price correlate with its fundamentals
Growth
What is Tonix Pharmaceuticals Holding's growth rate over time
Valuation
What is Tonix Pharmaceuticals Holding stock price valuation
P/E
N/A
P/B
1.34
P/S
22.25
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.43
TNXP's EPS has soared by 83% YoY
The P/B is 123% higher than the 5-year quarterly average of 0.6
The company's equity has surged by 67% YoY and by 29% QoQ
The company's revenue fell by 2% YoY
Efficiency
How efficient is Tonix Pharmaceuticals Holding business performance
TNXP's return on invested capital has dropped by 164% year-on-year and by 28% since the previous quarter
TNXP's ROA has shrunk by 51% YoY but it is up by 10% QoQ
The company's return on equity fell by 46% YoY but it rose by 15% QoQ
TNXP's ROS is down by 37% YoY
Dividends
What is TNXP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TNXP.
Financial health
How did Tonix Pharmaceuticals Holding financials performed over time
TNXP's quick ratio has soared by 99% from the previous quarter
The current ratio has surged by 89% since the previous quarter
The debt is 100% smaller than the equity
The debt to equity has plunged by 100% from the previous quarter and by 100% YoY
The debt has dropped by 94% year-on-year and by 93% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.